Citigroup’s Biolase, Inc. BIOL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-20
| Closed | -$561 | – | 4960 |
|
|
2023
Q1 | $561 | Buy |
+20
| New | +$561 | ﹤0.01% | 4465 |
|
|
2016
Q2 | – | Hold |
0
| – | -$1K | – | 5338 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 5245 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 5706 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 5793 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 5701 |
|
|
2014
Q4 | – | Hold |
0
| – | -$3K | – | 5647 |
|
|
2014
Q3 | – | Hold |
0
| – | -$7K | – | 5100 |
|
|
2014
Q2 | – | Sell |
-1
| Closed | -$18K | – | 4699 |
|
|
2014
Q1 | $18K | Hold |
1
| – | – | ﹤0.01% | 4557 |
|
|
2013
Q4 | $47K | Buy |
+1
| New | +$47K | ﹤0.01% | 4187 |
|
|
2013
Q3 | – | Hold |
0
| – | -$4K | – | 5051 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 4759 |
|